大型骨科手术中的序贯性旁路止血剂：一种新的止血方法。
Sequential bypassing agents during major orthopedic surgery: a new approach to hemostasis.
作者信息
Seaman Craig D, Ragni Margaret V
机构信息
Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA; and.
Hemophilia Center of Western Pennsylvania, Pittsburgh, PA.
出版信息
Blood Adv. 2017 Jul 18;1(17):1309-1311. doi: 10.1182/bloodadvances.2017008409. eCollection 2017 Jul 25.
Abstract
Sequential bypassing agents may be a safe and effective treatment during major orthopedic surgery in hemophilia patients with inhibitors.
摘要
对于患有抑制剂的血友病患者，在进行大型骨科手术期间，序贯旁路制剂可能是一种安全有效的治疗方法。
相似文献
1
Sequential bypassing agents during major orthopedic surgery: a new approach to hemostasis.大型骨科手术中的序贯性旁路止血剂：一种新的止血方法。
Blood Adv. 2017 Jul 18;1(17):1309-1311. doi: 10.1182/bloodadvances.2017008409. eCollection 2017 Jul 25.
2
Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors.血友病及抑制物患者择期骨科手术中的争议与挑战。
Semin Hematol. 2008 Apr;45(2 Suppl 1):S64-7. doi: 10.1053/j.seminhematol.2008.03.009.
3
Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.择期骨科手术治疗血友病伴抑制物患者：40 例手术的单中心经验及文献复习。
Haemophilia. 2011 Nov;17(6):910-9. doi: 10.1111/j.1365-2516.2011.02504.x. Epub 2011 Feb 22.
4
Use of FEIBA for invasive or surgical procedures in patients with severe hemophilia A or B with inhibitors.
J Pediatr Hematol Oncol. 2007 Apr;29(4):216-21. doi: 10.1097/MPH.0b013e318041f101.
5
Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors.序贯联合旁路活性物治疗可安全有效地治疗血友病合并抑制物的成人和儿童患者的无反应性出血。
Haemophilia. 2011 Jul;17(4):630-5. doi: 10.1111/j.1365-2516.2010.02467.x. Epub 2011 Feb 15.
6
Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors.对旁路制剂的不同反应使血友病和抑制剂患者的治疗复杂化。
Haemophilia. 2009 Jan;15(1):3-10. doi: 10.1111/j.1365-2516.2008.01931.x. Epub 2008 Nov 10.
7
Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.使用血栓生成分析（TGA）监测有抑制剂的血友病患者旁路治疗药物的可行性。
Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):389-94. doi: 10.1177/1076029612438611. Epub 2012 Mar 5.
8
Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors.成功地对有因子 VIII 抑制剂的血友病 A 患者进行大、小手术，利用了因子 VIII 抑制剂旁路活性。
Haemophilia. 2009 Nov;15(6):1300-7. doi: 10.1111/j.1365-2516.2008.01873.x. Epub 2009 Jul 29.
9
Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care.
Haemophilia. 2009 Jan;15(1):227-39. doi: 10.1111/j.1365-2516.2008.01840.x. Epub 2008 Aug 25.
10
Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.重组活化凝血因子 VII 用于高滴度抑制物血友病患者重度膝关节手术及晚期膝关节炎的经济学评价：基于文献建模的探索性结果
Curr Med Res Opin. 2008 Mar;24(3):753-68. doi: 10.1185/030079908X273048. Epub 2008 Jan 29.
引用本文的文献
1
Sequential combined bypassing therapy in haemophilia patients with high titer inhibitors: surgical experience.高滴度抑制物血友病患者的序贯联合旁路治疗：手术经验
Ann Hematol. 2025 Mar;104(3):1949-1960. doi: 10.1007/s00277-025-06265-6. Epub 2025 Feb 26.
2
Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders.活化重组凝血因子 VIIa（诺其）在治疗血友病和罕见出血性疾病中的现状和未来前景。
Ann Hematol. 2024 Aug;103(8):2647-2658. doi: 10.1007/s00277-023-05287-2. Epub 2023 Jun 30.
本文引用的文献
1
Impact of inhibitors on hemophilia A mortality in the United States.抑制剂对美国甲型血友病死亡率的影响。
Am J Hematol. 2015 May;90(5):400-5. doi: 10.1002/ajh.23957. Epub 2015 Feb 5.
2
Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomes.旁路制剂治疗血友病抑制物患者的研究进展：缩小护理差距，改善治疗结局。
Ther Adv Drug Saf. 2011 Oct;2(5):213-25. doi: 10.1177/2042098611415566.
3
Major surgery in severe haemophilia A with inhibitors using a recombinant factor VIIa and activated prothrombin complex concentrate hybrid regimen.
Haemophilia. 2014 Jul;20(4):587-92. doi: 10.1111/hae.12365. Epub 2014 Feb 11.
4
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.VIII 因子治疗强度与严重 A 型血友病儿童抑制剂发展：RODIN 研究。
Blood. 2013 May 16;121(20):4046-55. doi: 10.1182/blood-2012-09-457036. Epub 2013 Apr 3.
5
Consensus recommendations for the use of FEIBA(®) in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery.用于接受择期骨科和非骨科手术的血友病 A 伴抑制物患者的 FEIBA(®)使用共识建议。
Haemophilia. 2013 Mar;19(2):294-303. doi: 10.1111/hae.12028. Epub 2012 Sep 19.
6
Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors.序贯联合旁路活性物治疗可安全有效地治疗血友病合并抑制物的成人和儿童患者的无反应性出血。
Haemophilia. 2011 Jul;17(4):630-5. doi: 10.1111/j.1365-2516.2010.02467.x. Epub 2011 Feb 15.
7
Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.重组活化凝血因子 VII [eptacog alfa（活化型）；诺其] 在有抑制物的血友病患者择期骨科手术中应用的共识方案。
Haemophilia. 2009 Mar;15(2):501-8. doi: 10.1111/j.1365-2516.2008.01952.x. Epub 2009 Feb 1.
8
Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care.
Haemophilia. 2009 Jan;15(1):227-39. doi: 10.1111/j.1365-2516.2008.01840.x. Epub 2008 Aug 25.
9
Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors.重组凝血因子VIIa使用的安全性更新以及用抑制剂治疗先天性和获得性VIII或IX因子缺乏症
Haemophilia. 2008 Sep;14(5):898-902. doi: 10.1111/j.1365-2516.2008.01829.x. Epub 2008 Aug 4.
10
Factor VIII inhibitor bypassing activity (FEIBA) - addressing safety issues.凝血因子 VIII 抑制物旁路活性药物（FEIBA）——解决安全问题。
Haemophilia. 2008 Jan;14(1):39-43. doi: 10.1111/j.1365-2516.2007.01594.x. Epub 2007 Oct 22.
Zotero 插件